Dundee Corporation Acquires Further Interest in Diagnos Inc.

TORONTO, ONTARIO--(Marketwire - Feb. 8, 2013) - In accordance with regulatory requirements, Dundee Corporation (TSX:DC.A) ("Dundee") announces that it has acquired 6,000,000 units ("Units") of Diagnos Inc. ("Diagnos") in a private placement at a price of $0.10 per Unit. Each Unit consists of one common share in the capital of Diagnos and one common share purchase warrant ("Warrant"). Each Warrant entitles the holder to purchase one common share at the price of $0.15 for a period of 18 months.

Dundee now owns a position in Diagnos representing an approximate 14.98% interest or 22.96% assuming the exercise of all Warrants.

The position in Diagnos was acquired for investment purposes and may be increased or decreased in the future as considered appropriate in light of investment criteria, market conditions and other factors and in accordance with the provisions of applicable securities legislation.